Literature DB >> 19164801

Soluble Flt-1 gene transfer ameliorates neointima formation after wire injury in flt-1 tyrosine kinase-deficient mice.

Jun-ichiro Koga1, Tetsuya Matoba, Kensuke Egashira, Mitsuki Kubo, Miho Miyagawa, Eiko Iwata, Katsuo Sueishi, Masabumi Shibuya, Kenji Sunagawa.   

Abstract

OBJECTIVE: We have demonstrated that vascular endothelial growth factor (VEGF) expression is upregulated in injured vascular wall, and blockade of VEGF inhibited monocyte infiltration and neointima formation in several animal models. In the present study, we aimed to clarify relative role of two VEGF receptors, flt-1 versus flk-1/KDR, in neointima formation after injury using flt-1 tyrosine kinase-deficient (Flt-1 TK(-/-)) mice and soluble Flt-1(sFlt-1) gene transfer. METHODS AND
RESULTS: Neointima formation was comparable between wild-type and Flt-1 TK(-/-) mice 28 days after intraluminal wire injury in femoral arteries. By contrast, neointima formation was significantly suppressed by sFlt-1 gene transfer into Flt-1 TK(-/-) mice that blocks VEGF action on flk-1 (intima/media ratio: 2.8+/-0.4 versus 1.4+/-0.4, P<0.05). The inhibition of neointima formation was preceded by significant reduction of monocyte chemoattractant protein (MCP-1) expression in vascular smooth muscle cells (VSMCs) and monocyte infiltration 7 days after injury. Gene transfer of sFlt-1 or treatment of flk-1-specific antibody significantly inhibited VEGF-induced MCP-1 expression determined by RT-PCR in cultured aortic tissue and VSMCs. MCP-1-induced chemotaxis was equivalent between wild-type and Flt-1 TK(-/-) mice.
CONCLUSIONS: These results suggest that endogenous VEGF accelerates neointima formation through flk-1 by regulating MCP-1 expression in VSMCs and macrophage-mediated inflammation in injured vascular wall in murine model of wire injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19164801     DOI: 10.1161/ATVBAHA.109.183772

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  11 in total

1.  VEGF blockade inhibits lymphocyte recruitment and ameliorates immune-mediated vascular remodeling.

Authors:  Jiasheng Zhang; Teresa Silva; Timur Yarovinsky; Thomas D Manes; Sina Tavakoli; Lei Nie; George Tellides; Jordan S Pober; Jeffrey R Bender; Mehran M Sadeghi
Journal:  Circ Res       Date:  2010-06-10       Impact factor: 17.367

Review 2.  Integrin signaling in atherosclerosis.

Authors:  Alexandra C Finney; Karen Y Stokes; Christopher B Pattillo; A Wayne Orr
Journal:  Cell Mol Life Sci       Date:  2017-02-28       Impact factor: 9.261

3.  VEGF and restenosis: the rest of the story.

Authors:  Michael Simons
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04       Impact factor: 8.311

4.  High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism.

Authors:  Federico Biscetti; Giuseppe Straface; Raimondo De Cristofaro; Stefano Lancellotti; Paola Rizzo; Vincenzo Arena; Egidio Stigliano; Giovanni Pecorini; Kensuke Egashira; Giulia De Angelis; Giovanni Ghirlanda; Andrea Flex
Journal:  Diabetes       Date:  2010-03-03       Impact factor: 9.461

5.  CD40 is essential in the upregulation of TRAF proteins and NF-kappaB-dependent proinflammatory gene expression after arterial injury.

Authors:  Zifang Song; Rong Jin; Shiyong Yu; Joshua J Rivet; Susan S Smyth; Anil Nanda; D Neil Granger; Guohong Li
Journal:  PLoS One       Date:  2011-08-18       Impact factor: 3.240

6.  Anti‑angiogenesis gene therapy for hepatocellular carcinoma via systemic injection of mesenchymal stem cells engineered to secrete soluble Flt‑1.

Authors:  Guanglin Li; Fei Miao; Jinhai Zhu; Yanling Chen
Journal:  Mol Med Rep       Date:  2017-08-22       Impact factor: 2.952

7.  A computational model predicting disruption of blood vessel development.

Authors:  Nicole Kleinstreuer; David Dix; Michael Rountree; Nancy Baker; Nisha Sipes; David Reif; Richard Spencer; Thomas Knudsen
Journal:  PLoS Comput Biol       Date:  2013-04-04       Impact factor: 4.475

8.  Pitavastatin Reduces Inflammation in Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice with Late Stage Renal Disease.

Authors:  Manabu Shibasaki; Jian-Guo Wang; Jose-Luiz Figueiredo; Sophie E P New; Thibaut Quillard; Claudia Goettsch; Jun-ichiro Koga; Hiroyuki Sonoki; Jiro Matsumoto; Masanori Aikawa; Elena Aikawa
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

9.  TGF-β/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A.

Authors:  X Shi; L-W Guo; S M Seedial; Y Si; B Wang; T Takayama; P A Suwanabol; S Ghosh; D DiRenzo; B Liu; K C Kent
Journal:  Cell Death Dis       Date:  2014-07-10       Impact factor: 8.469

10.  VEGFR1-positive macrophages facilitate liver repair and sinusoidal reconstruction after hepatic ischemia/reperfusion injury.

Authors:  Hirotoki Ohkubo; Yoshiya Ito; Tsutomu Minamino; Koji Eshima; Ken Kojo; Shin-ichiro Okizaki; Mitsuhiro Hirata; Masabumi Shibuya; Masahiko Watanabe; Masataka Majima
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.